A Novel Druggable Epigenetic Vulnerability Pathway in Hepatocellular Carcinoma (HCC)

Grant

Date/time Interval

  • June 1, 2019 - March 31, 2023
  • Total Award Amount

  • 429757.00
  • Direct Costs

  • 289399.00
  • Sponsor Award Id

  • OSP2018062
  • Contributor

  • Narendra Wajapeyee   Principal Investigator